Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating oral VT-1161 for moderate to severe interdigital tinea pedis has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Pedis

Drugs mentioned

• VT-1161 (VT-1161)

Snippet

Sponsor: Viamet | Conditions: Tinea Pedis | Phase 2 | Status: COMPLETED | Results posted: 2018-07-06